DermTech

$48.50
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$10.99 (-17.18%) Today
-$4.48 (-8.46%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell DermTech and other stocks, options, and ETFs commission-free!

About DMTK

DermTech, Inc. Common Stock, also called DermTech, is a genomics company in dermatology, which engages in the development and sale of products for the diagnosis and treatment of skin diseases. It markets and develops products that facilitate the early detection of skin cancers, assesses inflammatory diseases, and customizes drug treatments. Its products include adhesive skin collection kit, pigmented lesion assay, nevome, and carcinome. The company was founded in 1995 and is headquartered in La Jolla, CA. The listed name for DMTK is DermTech, Inc. Common Stock.

CEO
John D. Dobak
Employees
—
Headquarters
La Jolla, California
Founded
1995
Market Cap
1.24B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.71M
High Today
$64.57
Low Today
$52.10
Open Price
$62.96
Volume
2.91M
52 Week High
$84.49
52 Week Low
$8.69

DMTK Earnings

-$0.93
-$0.62
-$0.31
-$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
-$0.55 per share
Actual
-$0.48 per share
Replay Earnings Call

You May Also Like

VNO
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure